Cambridge Investment Research Advisors »

Ascendis Pharma AS shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $454k 1.7k 266.43

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corp Com (MSFT)
Capital Group Dividend Value Shs Creat Unit (CGDV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Inc Cap Stk Cl A (GOOGL)
Alphabet Inc Cap Stk Cl C (GOOG)
Spdr Series Trust St Str P500etf (SPYM)

View all positions for Cambridge Investment Research Advisors

Top funds holding Ascendis Pharma AS

T. Rowe Price Associates
Principal Financial Group
Bank of New York Mellon
Pictet Asset Management Holding SA
A.R. Schmeidler & Co
New York State Common Retirement Fund
Stacey Braun Associates
Walleye Trading Advisors
Driehaus Capital Management
TD Asset Management
Fiera Capital Corporation
Q Global Advisors
Sapient Capital
Walleye Trading
Russell Investments

View all funds holding Ascendis Pharma AS